Evidence map›Paper›PMID 31236031›Full record

ArticleTurk pediatri arsivi2018

Turkish Neonatal Society guideline for the follow-up of high-risk newborn infants.

Betul Acunaş, Sinan Uslu, Ahmet Yağmur Baş

Registry-linked trialAbstract read
In one paragraph

Article in Turk pediatri arsivi, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07324941 (The Role of Electroencephalography Evaluation in Caffeine Discontinuation Timing in Premature Infants), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07324941 recruitingnot on this mapstarted 2026, after this paper: background citation

The Role of Electroencephalography Evaluation in Caffeine Discontinuation Timing in Premature Infants

Typeobservational_patient_registrySponsorUludag UniversityRan2026 to 2027Enrolled100ConditionsApnea Neonatal, Apnea of Prematurity
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Overview of Pediatric Respiratory Syncytial Virus (RSV) infections: has risk perception for RSV changed in children with comorbid conditions?European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Betul AcunaşDivision of Neonatology, Department of Pediatrics, Trakya University, Faculty of Medicine, Edirne, Turkey.
Sinan UsluNeonatology Clinic, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey.
Ahmet Yağmur BaşDivision of Neonatology, Department of Pediatrics, Yıldırım Beyazıt University, Faculty of Medicine, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developments in perinatal and neonatal care have increased the survival rate of high-risk newborns but led to a rise in chronic diseases seen in these infants. A significant number of them attend primary and secondary health care centers after discharge; however, there are very few standard protocols for the long-term follow-up of these babies. Therefore, we aimed to establish a follow-up guideline that emphasizes on universal screening schemes and takes into consideration national data. The guide presented here provides brief recommendations for physicians in light of evidence-based data for the follow-up of high-risk newborn infants. The steps taken to monitor and solve the problems of all high-risk infants may vary. We hope the use of such a standard approach in evaluating each infant in daily routine will improve the life quality of these high-risk infants.

Indexed as

Follow-upguidelinehigh-risknewborn

Identifiers

PMID31236031
PMCPMC6568304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.